Showing results (81-90 of 297) with videos related to
Sort By:
Pageof 30
Academic Radiology|August 21, 2018
Reduced Contrast Volume and Radiation Dose During Computed Tomography of the Pancreas: Timing-Specific Contrast Media ProtocolCharbel Saade, Jad Chokr, Lena Naffaa, et al.Gene|June 9, 2022
Tumor profiling of KRAS, BRAF, and NRAS gene mutations in patients with colorectal cancer: A Lebanese major center cohort studyOmar Baba, Aram Bidikian, Deborah Mukherji, et al.Urology Annals|November 11, 2021
High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care centerMarilyne Daher, Talar Telvizian, Christelle Dagher, et al.Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2017
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective AnalysisArafat Tfayli, Hind Rafei, Alain Mina, et al.Critical Reviews in Oncology/Hematology|December 3, 2013
Metastatic castration resistant prostate cancer: current strategies of management in the Middle EastShouki Bazarbashi, Marwan Bachour, Muhammad Bulbul, et al.Future Oncology (London, England)|August 25, 2025
Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01)Ali Shamseddine, Noura Abbas, Sally Temraz, et al.Nuclear Medicine Communications|December 7, 2016
The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centersMohamad Haidar, Ali Shamseddine, Emmanouil Panagiotidis, et al.Clinical Imaging|March 21, 2016
Pancreatic neuroendocrine tumor with aneurysms of the gastroduodenal artery: a case reportKarim Rebeiz, Ali Shamseddine, Ralph Hachem, et al.World Journal of Surgical Oncology|April 27, 2012
Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle EastElias Elias, Deborah Mukherji, Walid Faraj, et al.Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trialsPaolo Prandoni, Sally Temraz, Ali TaherPageof 30